Bruno Montanari
Investing Profile
Sweet spot: $1.5M
Range: $100K–$5M
Seroba Life Sciences thesis
The Millipede88® is the first 088 aspiration catheter with patented corrugated technology cleared for standalone direct aspiration – no large-bore intermediary required- backed by independently adjudicated MARRS study data showing a 77% first-pass effect1 in M1 occlusions and 96% delivery success. Perfuze, a medical device company dedicated to advancing stroke treatment through next-generation catheter technology, today announced it has received … Medtech Explore Europe is a science powerhouse, but can it also lead in biotech and healthcare innovation? That’s the pressing question at the heart
Sector and stage focus
- Seed: Medical Devices, BioTech, Consumer Health, Health IT, Health & Hospital Services
- Series A: Consumer Health, Medical Devices, Health IT, BioTech, Health & Hospital Services
Is Bruno Montanari a fit for your round?
Upload your pitch deck and see whether Bruno Montanari appears in your top 20 matches.
Find investors for your deck